← back to search

Isidro Sánchez‐García

Instituto de Investigación Biomédica de Salamanca · ES
Area of research
Public Health, Environmental and Occupational Health · Hematology
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, and Epigenetics and DNA Methylation.
h-index
49
citations
8,353
works
228
NIH funding
primary concept
Biology
email

Recent publications

Loss of p53 enhances LMO2 induced transdifferentiation of  B-cells to T-cell acute lymphoblastic leukemia
Blood 2025cited by 0position: middledoi
PD-1 Expression Promotes Immune Evasion in B-ALL.
2025cited by 0position: contributordoi
PD-1 Expression Promotes Immune Evasion in B-ALL
2025cited by 0position: contributordoi
Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.
2024cited by 14position: contributordoi
Childhood B cell leukemia: Intercepting the paths to progression.
2024cited by 2position: contributordoi
Childhood leukemia prevention within reach.
2024cited by 0position: contributordoi
Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.
2023cited by 11position: contributordoi
Editorial: Special Issue "Stem Cell Biology and Cancer".
2023cited by 0position: contributordoi
Data from Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
2023cited by 0position: contributordoi
Supplementary Data from Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
2023cited by 0position: contributordoi
Supplementary Data from Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
2023cited by 0position: contributordoi
Supplementary Data from Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
2023cited by 0position: contributordoi
Data from Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
2023cited by 0position: contributordoi
Supplementary Data from Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
2023cited by 0position: contributordoi
Supplementary Data from Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
2023cited by 0position: contributordoi
Supplementary Data from Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
2023cited by 0position: contributordoi
Preneoplastic somatic mutations including <i>MYD88</i><sup>L265P</sup> in lymphoplasmacytic lymphoma.
2022cited by 29position: contributordoi
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice.
2022cited by 13position: contributordoi
Revisiting the concept of childhood preleukemia.
2022cited by 3position: contributordoi
Childhood B-Cell Preleukemia Mouse Modeling.
2022cited by 3position: contributordoi
Risk Factors for Childhood Leukemia: Radiation and Beyond
Frontiers in Public Health 2021cited by 45position: middledoi
Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia.
2021cited by 29position: contributordoi
Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice
Blood 2021cited by 6position: contributordoi
An intact gut microbiome protects genetically predisposed mice against leukemia
Blood 2020cited by 104position: middledoi
An intact gut microbiome protects genetically predisposed mice against leukemia.
2020cited by 83position: contributordoi
Lineage Decision-Making within Normal Haematopoietic and Leukemic Stem Cells.
2020cited by 2position: contributordoi
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL
Cancer Cell 2019cited by 93position: middledoi
Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID.
2019cited by 26position: contributordoi
Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling.
2019cited by 7position: contributordoi
Are Leukaemic Stem Cells Restricted to a Single Cell Lineage?
2019cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 25 papers (2019–2025) · 18 papers (2019–2025)Cesar Cobaleda · Centro de Investigación del Cáncer16 papers (2021–2025)Javier De Las Rivas · Universidad de Salamanca15 papers (2012–2023)Kim E. Nichols · University of Alabama14 papers (2022–2025) · 13 papers (2020–2023) · 13 papers (2019–2023)Pablo Prieto-Matos · Hospital Universitario de Salamanca13 papers (2022–2025) · 12 papers (2022–2025) · 11 papers (2022–2025) · 11 papers (2019–2023) · 11 papers (2022–2025) · 9 papers (2022–2023)Andrea Mayado · Universidad de Salamanca9 papers (2022–2023)Elena G. Sánchez · Universidad Autónoma de Madrid9 papers (2022–2023)Izidore S. Lossos · University of Miami7 papers (2012–2025)Manuel Ramírez-Orellana · Universidad Politécnica Metropolitana de Hidalgo4 papers (2022–2025)Ute Fischer · Hospital Clínic de Barcelona4 papers (2019–2021)Carolina Vicente‐Dueñas · Universidad de Salamanca4 papers (2012–2025)Inés González‐Herrero · Centro de Investigación del Cáncer3 papers (2012–2020)